Widely prescribed, newer-generation antipsychotic drugs are no more effective for the treatment of schizophrenia in children and teens than older, cheaper drugs, a government-funded study shows.
Under the direction of the National Institute of Mental Health (NIMH), researchers compared two of the newer drugs, known as atypical antipsychotics, to an older-generation antipsychotic. They found no major differences in treatment outcomes, but big differences in side effects among young patients taking the newer and older drugs.
Newer Antipsychotics No Better in Kids
President Barack Obama has announced a new initiative at the National Institutes of Health in pursuit...
A growing body of research on conditions from bipolar disorder to schizophrenia to depression is starting...
Major international divisions over the global "war on drugs" have been revealed in a leaked draft...
